BIOMAT Database Logo BIOMAT Database Logo

Enhanced alpha-adrenoceptor-mediated vasoconstriction contributes to increased vascular resistance in essential hypertension. 1984

P Bolli, and W Kiowski, and P Erne, and W Amann, and B H Ji, and L Block, and F R Bühler

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D009599 Nitroprusside A powerful vasodilator used in emergencies to lower blood pressure or to improve cardiac function. It is also an indicator for free sulfhydryl groups in proteins. Nitroferricyanide,Sodium Nitroprusside,Cyanonitrosylferrate,Ketostix,Naniprus,Nipride,Nipruton,Nitriate,Nitropress,Nitroprussiat Fides,Nitroprusside, Disodium Salt,Nitroprusside, Disodium Salt, Dihydrate,Disodium Salt Nitroprusside,Nitroprusside, Sodium
D011224 Prazosin A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION. Furazosin,Minipress,Pratsiol,Prazosin HCL,Prazosin Hydrochloride,HCL, Prazosin,Hydrochloride, Prazosin
D011942 Receptors, Adrenergic, alpha One of the two major pharmacological subdivisions of adrenergic receptors that were originally defined by the relative potencies of various adrenergic compounds. The alpha receptors were initially described as excitatory receptors that post-junctionally stimulate SMOOTH MUSCLE contraction. However, further analysis has revealed a more complex picture involving several alpha receptor subtypes and their involvement in feedback regulation. Adrenergic alpha-Receptor,Adrenergic alpha-Receptors,Receptors, alpha-Adrenergic,alpha-Adrenergic Receptor,alpha-Adrenergic Receptors,Receptor, Adrenergic, alpha,Adrenergic alpha Receptor,Adrenergic alpha Receptors,Receptor, alpha-Adrenergic,Receptors, alpha Adrenergic,alpha Adrenergic Receptor,alpha Adrenergic Receptors,alpha-Receptor, Adrenergic,alpha-Receptors, Adrenergic
D004837 Epinephrine The active sympathomimetic hormone from the ADRENAL MEDULLA. It stimulates both the alpha- and beta- adrenergic systems, causes systemic VASOCONSTRICTION and gastrointestinal relaxation, stimulates the HEART, and dilates BRONCHI and cerebral vessels. It is used in ASTHMA and CARDIAC FAILURE and to delay absorption of local ANESTHETICS. Adrenaline,4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol,Adrenaline Acid Tartrate,Adrenaline Bitartrate,Adrenaline Hydrochloride,Epifrin,Epinephrine Acetate,Epinephrine Bitartrate,Epinephrine Hydrochloride,Epinephrine Hydrogen Tartrate,Epitrate,Lyophrin,Medihaler-Epi,Acetate, Epinephrine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013569 Synapses Specialized junctions at which a neuron communicates with a target cell. At classical synapses, a neuron's presynaptic terminal releases a chemical transmitter stored in synaptic vesicles which diffuses across a narrow synaptic cleft and activates receptors on the postsynaptic membrane of the target cell. The target may be a dendrite, cell body, or axon of another neuron, or a specialized region of a muscle or secretory cell. Neurons may also communicate via direct electrical coupling with ELECTRICAL SYNAPSES. Several other non-synaptic chemical or electric signal transmitting processes occur via extracellular mediated interactions. Synapse
D014655 Vascular Resistance The force that opposes the flow of BLOOD through a vascular bed. It is equal to the difference in BLOOD PRESSURE across the vascular bed divided by the CARDIAC OUTPUT. Peripheral Resistance,Total Peripheral Resistance,Pulmonary Vascular Resistance,Systemic Vascular Resistance,Peripheral Resistance, Total,Resistance, Peripheral,Resistance, Pulmonary Vascular,Resistance, Systemic Vascular,Resistance, Total Peripheral,Resistance, Vascular,Vascular Resistance, Pulmonary,Vascular Resistance, Systemic
D014661 Vasoconstriction The physiological narrowing of BLOOD VESSELS by contraction of the VASCULAR SMOOTH MUSCLE. Vasoconstrictions
D015016 Yohimbine A plant alkaloid with alpha-2-adrenergic blocking activity. Yohimbine has been used as a mydriatic and in the treatment of ERECTILE DYSFUNCTION. Rauwolscine,Aphrodine Hydrochloride,Aphrodyne,Corynanthine,Corynanthine Tartrate,Pluriviron,Rauhimbine,Yocon,Yohimbin Spiegel,Yohimbine Houdé,Yohimbine Hydrochloride,Yohimex,Hydrochloride, Aphrodine,Hydrochloride, Yohimbine,Tartrate, Corynanthine

Related Publications

P Bolli, and W Kiowski, and P Erne, and W Amann, and B H Ji, and L Block, and F R Bühler
Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension.
September 1987, The Journal of clinical investigation,
P Bolli, and W Kiowski, and P Erne, and W Amann, and B H Ji, and L Block, and F R Bühler
Alpha 2 adrenoceptor-mediated vasoconstriction of arteries.
November 1983, Clinical pharmacology and therapeutics,
P Bolli, and W Kiowski, and P Erne, and W Amann, and B H Ji, and L Block, and F R Bühler
Tissue specific susceptibility of alpha-adrenoceptor mediated vasoconstriction to nifedipine.
September 1983, Naunyn-Schmiedeberg's archives of pharmacology,
P Bolli, and W Kiowski, and P Erne, and W Amann, and B H Ji, and L Block, and F R Bühler
Vasoconstriction mediated by postsynaptic alpha 2-adrenoceptor stimulation.
August 1980, Naunyn-Schmiedeberg's archives of pharmacology,
P Bolli, and W Kiowski, and P Erne, and W Amann, and B H Ji, and L Block, and F R Bühler
Potentiation of alpha-adrenoceptor-mediated vasoconstriction by sumatriptan.
October 1993, Lancet (London, England),
P Bolli, and W Kiowski, and P Erne, and W Amann, and B H Ji, and L Block, and F R Bühler
Renal alpha 1- and alpha 2-adrenoceptor mediated vasoconstriction in dogs.
December 1984, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
P Bolli, and W Kiowski, and P Erne, and W Amann, and B H Ji, and L Block, and F R Bühler
Angiotensin II-mediated renal vasoconstriction amenable to alpha 1-adrenoceptor blockade.
September 1995, European journal of pharmacology,
P Bolli, and W Kiowski, and P Erne, and W Amann, and B H Ji, and L Block, and F R Bühler
Alpha 2-adrenoceptor-mediated vasoconstriction requires a tyrosine kinase.
April 1995, European journal of pharmacology,
P Bolli, and W Kiowski, and P Erne, and W Amann, and B H Ji, and L Block, and F R Bühler
Postsynaptic adrenoceptor-mediated vasoconstriction in coronary and femoral vascular beds.
May 1988, The American journal of physiology,
P Bolli, and W Kiowski, and P Erne, and W Amann, and B H Ji, and L Block, and F R Bühler
Increased beta-adrenoceptor binding capacity is associated with blunted beta-adrenoceptor-mediated cardiovascular responses in essential hypertension.
January 1985, Journal of cardiovascular pharmacology,
Copied contents to your clipboard!